- Home
- OTLK vs ICLK Comparison
OTLK vs ICLK Comparison
Compare OTLK & ICLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTLK
- ICLK
- Stock Information
- Founded
- OTLK 2010
- ICLK 2009
- Country
- OTLK United States
- ICLK Hong Kong
- Employees
- OTLK N/A
- ICLK N/A
- Industry
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- ICLK Computer Software: Prepackaged Software
- Sector
- OTLK Health Care
- ICLK Technology
- Exchange
- OTLK Nasdaq
- ICLK Nasdaq
- Market Cap
- OTLK 56.3M
- ICLK 67.5M
- IPO Year
- OTLK 2016
- ICLK 2017
- Fundamental
- Price
- OTLK $1.48
- ICLK $9.24
- Analyst Decision
- OTLK Strong Buy
- ICLK
- Analyst Count
- OTLK 5
- ICLK 0
- Target Price
- OTLK $10.20
- ICLK N/A
- AVG Volume (30 Days)
- OTLK 467.0K
- ICLK 82.5K
- Earning Date
- OTLK 02-14-2025
- ICLK 11-27-2024
- Dividend Yield
- OTLK N/A
- ICLK N/A
- EPS Growth
- OTLK N/A
- ICLK N/A
- EPS
- OTLK N/A
- ICLK N/A
- Revenue
- OTLK N/A
- ICLK $130,444,000.00
- Revenue This Year
- OTLK N/A
- ICLK $26.49
- Revenue Next Year
- OTLK $288.46
- ICLK $12.11
- P/E Ratio
- OTLK N/A
- ICLK N/A
- Revenue Growth
- OTLK N/A
- ICLK N/A
- 52 Week Low
- OTLK $0.87
- ICLK $1.03
- 52 Week High
- OTLK $12.85
- ICLK $11.38
- Technical
- Relative Strength Index (RSI)
- OTLK 41.52
- ICLK 63.22
- Support Level
- OTLK $1.38
- ICLK $5.75
- Resistance Level
- OTLK $1.56
- ICLK $7.14
- Average True Range (ATR)
- OTLK 0.12
- ICLK 0.80
- MACD
- OTLK 0.02
- ICLK 0.22
- Stochastic Oscillator
- OTLK 59.26
- ICLK 82.70
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About ICLK iClick Interactive Asia Group Limited
iClick Interactive Asia Group Ltd is an enterprise and marketing cloud Platform in China. It offers a consumer full lifecycle solution that addresses client's needs from traffic acquisition, customer relations management, and business decision optimization driven by data analytics in the retail era. It has two operating segments: Marketing Solutions, and Enterprise Solutions. Geographically, it derives the majority revenue from Mainland China and also has a presence in Hong Kong and other countries.